Proliferation characteristics of canine transmissible venereal tumor.
Canine transmissible venereal tumor (CTVT) grows progressively (P-phase) in the host and then spontaneously regresses (R-phase). The mechanisms behind the transition from the P-to R-phases are not well understood. In this study, in order to determine the proliferation characteristics of CTVT, we evaluated telomerase activity and enumerated nuclear organizing regions (AgNOR) and proliferating cell nuclear antigen (PCNA). It was found that CTVT cells from the P-and R-phases were both positive for telomerase activity, although it was lower in the R-phase. Evaluations of telomerase activity should take into account the stage of mitosis. Although, in the majority of cases, telomerase activity can be used to differentiate between benign and malignant tumors in dogs, other factors or markers should also be used to obtain accurate diagnoses. The PCNA-positive rate and the number and area of AgNOR per cell increased much more in the P-phase than the R-phase. However, the AgNOR values were always higher. Thus, the AgNOR count can be used to distinguish the P-and R-phases of CTVT. In addition, mitotic figures were much higher in number in the P-phase as compared to the R-phase. We believe that, during spontaneous regression of CTVT cells, slow tumor cell proliferation must contribute to the decrease in tumor size. However, shortening of tumor cell telomeres is not directly involved in this process. Other factors, such as expression of MHC antigens on CTVT cells, humoral immunity, cytokines released by the inflammatory cells and, especially, tumor infiltrating lymphocytes may contribute to CTVT regression.
Chu
R M
RM
Department of Veterinary Medicine, National Taiwan University, Taipei, ROC. redman@ms.cc.ntu.edu.tw
Lin
C Y
CY
Liu
C C
CC
Yang
S Y
SY
Hsiao
Y W
YW
Hung
S W
SW
Pao
H N
HN
Liao
K W
KW
D000818:Animals; D002455:Cell Division / Q000502:physiology; D004283:Dog Diseases / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D004285:Dogs; D009369:Neoplasms / Q000473:pathology / Q000662:veterinary*; D009697:Nucleolus Organizer Region; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis; D012749:Sexually Transmitted Diseases / Q000473:pathology / Q000662:veterinary*; D019098:Telomerase / Q000378:metabolism
D018809:Proliferating Cell Nuclear Antigen; D019098:Telomerase